Jon Gray C’92 W’92 and Mindy Gray C’92 have given $21 million to expand the capabilities of the Basser Center for BRCA, which sponsors basic research, clinical trials, and educational outreach for patients with or at risk for breast, ovarian, pancreatic, and other cancers involving mutations of the BRCA gene. The Grays have now committed $55 million to the Basser Center, which was established in 2012 with their support.
“The advancements we’ve made in understanding, treating, and preventing BRCA-related cancers in the past five years are astounding and would not have been possible without the generosity of Mindy and Jon Gray,” said Basser Center executive director Susan Domchek in a statement.
Among other accomplishments, the Basser Center designed and executed clinical trials leading to FDA approval of olaparib and rucaparib for BRCA-associated ovarian cancer. With the Grays’ newest gift, the center plans to support research on biomarkers for early detection of ovarian cancer, test strategies that use personalized cellular therapies such as CAR T-cell therapy [“The T-Cell Warriors,” Mar|Apr 2015], and extend the reach of preventive care and educational programs.